New diabetes clinical trial: Study on How Fiasp® Can Influence Blood Sugar Levels of type1 Diabetic Patients in Their Daily Lives, With the Help of the Freestyle Libre® Device

Published on: March 01, 2018 at 10:30PM
Conditions:   Diabetes;   Diabetes Mellitus, Type 1 Diabetes
Intervention:   Drug: Fast-acting insulin aspart
Sponsor:   Novo Nordisk A/S
Not yet recruiting
http://ift.tt/2HU800M